Related Experiment Video
Updated: Jul 23, 2025

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
Multiple system atrophy associated with Meige syndrome: A rare case report
Jiaji Liang1, Xi He1, Jinqiang Lu1
1Department of Plastic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Multiple system atrophy (MSA), a rare neurodegenerative disorder, can present with Meige syndrome, characterized by blepharospasm and oromandibular dystonia. This case report details the clinical features and treatment of this exceptionally rare co-occurrence.
Area of Science:
- Neuroscience
- Movement Disorders
- Rare Diseases
Background:
- Multiple system atrophy (MSA) is a rare adult-onset α-synucleinopathy.
- Meige syndrome is a focal dystonic movement disorder involving blepharospasm and oromandibular dystonia.
- The co-occurrence of MSA and Meige syndrome is extremely rare.
Observation:
- This case report focuses on a patient presenting with clinical features of both MSA and Meige syndrome.
- Detailed clinical observations of the patient's neurological and movement disorder symptoms are presented.
Findings:
- The study highlights the specific clinical manifestations of MSA in a patient with Meige syndrome.
- The report documents the patient's experience with treatments for Meige syndrome in the context of MSA.
Implications:
- This case provides valuable insights into the complex presentation of rare neurological conditions.
- Understanding this rare association may improve diagnosis and management strategies for patients with overlapping movement disorders.
- Further research is warranted to explore the pathophysiology and optimal therapeutic approaches for this specific patient population.
More Related Videos
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
13:02Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis
Published on: November 4, 2017
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...